Molecular Basis for T Cell Response Induced by Altered Peptide Ligand of Type II Collagen
2012 (English)In: Journal of Biological Chemistry, ISSN 0021-9258, E-ISSN 1083-351X, Vol. 287, no 23, 19765-19774 p.Article in journal (Refereed) Published
Mounting evidence from animal models has demonstrated that alterations in peptide-MHC interactions with the T cell receptor (TCR) can lead to dramatically different T cell outcomes. We have developed an altered peptide ligand of type II collagen, referred to as A9, which differentially regulates TCR signaling in murine T cells leading to suppression of arthritis in the experimental model of collagen-induced arthritis. This study delineates the T cell signaling pathway used by T cells stimulated by the A9.I-A(q) complex. We have found that T cells activated by A9 bypass the requirement for Zap-70 and CD3-zeta and signal via FcR gamma and Syk. Using collagen-specific T cell hybridomas engineered to overexpress either Syk, Zap-70, TCR-FcR gamma, or CD3-zeta, we demonstrate that A9.I-A(q) preferentially activates FcR gamma/Syk but not CD3-zeta/Zap-70. Moreover, a genetic absence of Syk or FcR gamma significantly reduces the altered peptide ligand induction of the nuclear factor GATA3. By dissecting the molecular mechanism of A9-induced T cell signaling we have defined a new alternate pathway that is dependent upon FcR gamma and Syk to secrete immunoregulatory cytokines. Given the interest in using Syk inhibitors to treat patients with rheumatoid arthritis, understanding this pathway may be critical for the proper application of this therapy.
Place, publisher, year, edition, pages
2012. Vol. 287, no 23, 19765-19774 p.
Biochemistry and Molecular Biology
IdentifiersURN: urn:nbn:se:uu:diva-259781DOI: 10.1074/jbc.M112.349688ISI: 000306411900085PubMedID: 22511761OAI: oai:DiVA.org:uu-259781DiVA: diva2:845430